ZNF627 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.50950371594172E-11 |
Normal-vs-Stage2 |
8.58789994673259E-09 |
Normal-vs-Stage3 |
1.62447832963153E-12 |
Normal-vs-Stage4 |
1.62547753035369E-12 |
Stage1-vs-Stage2 |
2.618000E-01 |
Stage1-vs-Stage3 |
2.14200002179865E-09 |
Stage1-vs-Stage4 |
4.47190000000264E-05 |
Stage2-vs-Stage3 |
2.918900E-03 |
Stage2-vs-Stage4 |
3.628400E-02 |
Stage3-vs-Stage4 |
5.934000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
1.29459998277071E-09 |
Normal-vs-Asian |
6.527800E-02 |
Caucasian-vs-AfricanAmerican |
5.094800E-01 |
Caucasian-vs-Asian |
2.592800E-01 |
AfricanAmerican-vs-Asian |
2.719400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11022302462516E-16 |
Normal-vs-Female |
1.62492241884138E-12 |
Male-vs-Female |
8.246400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.247600E-04 |
Normal-vs-Age(41-60Yrs) |
1.62581059726108E-12 |
Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(81-100Yrs) |
3.58520000021123E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.103200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.033400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.044400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.789800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.686200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.211600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.208100E-02 |
Normal-vs-Grade 2 |
1.0290002183666E-10 |
Normal-vs-Grade 3 |
3.21964677141295E-15 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
4.989400E-01 |
Grade 1-vs-Grade 3 |
2.499900E-02 |
Grade 1-vs-Grade 4 |
1.022100E-04 |
Grade 2-vs-Grade 3 |
5.94709999999221E-05 |
Grade 2-vs-Grade 4 |
5.32700550337495E-11 |
Grade 3-vs-Grade 4 |
3.65530000000502E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.22699997226772E-09 |
Normal-vs-ccB subtype |
1.62458935193399E-12 |
ccA subtype-vs-ccB subtype |
3.55320000000603E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62614366416847E-12 |
Normal-vs-N1 |
1.82500000001085E-06 |
N0-vs-N1 |
2.228800E-01 |
|
|